|
Ascorbic Acid
|
D02.241.081.844.107 |
|
|
Oesophagostomum
|
B01.050.500.500.294.400.968.710.600 |
|
|
Trypsinogen
|
D12.776.811.243.885 |
|
|
Enzyme Precursors
|
D12.776.811.243 |
|
|
Kidney Diseases, Cystic
|
C13.351.968.419.403 |
|
|
Hearing Loss, High-Frequency
|
C10.597.751.418.341.812 |
|
|
Mast Cells
|
A11.329.427 |
|
|
Acrosin
|
D08.811.277.656.959.350.030 |
|
|
Sverdlovsk Accidental Release
|
N06.850.135.190.500 |
|
|
Biohazard Release
|
N06.850.135.190 |
|
|
Pharmaceutical Vehicles
|
D27.720.744.770 |
|
|
Heptavalent Pneumococcal Conjugate Vaccine
|
D20.215.894.135.750.600.500 |
|
|
Pneumococcal Vaccines
|
D20.215.894.135.750.600 |
|
|
Pyruvate Dehydrogenase Complex Deficiency Disease
|
C10.228.140.163.100.750 |
|
|
Kidney Neoplasms
|
C13.351.968.419.473 |
|
|
Health Maintenance Organizations
|
N03.219.521.576.343.800.400 |
|
|
HLA-DRB5 Chains
|
D23.050.301.500.400.400.440.200.050 |
|
|
HLA-DR beta-Chains
|
D23.050.301.500.400.400.440.200 |
|
|
Allantoin
|
D03.383.129.308.432.555.105 |
|
|
Professional Practice Gaps
|
N04.590.374.650 |
|
